Jamie Rossjohn featured in the Australian Financial Review
Janssen Biotech funds Monash rheumatoid arthritis research
Janssen Biotech, part of global giant Johnson & Johnson, has agreed to fund research by a team of scientists led by one of Monash University’s star researchers into rheumatoid arthritis.
The landmark deal means Janssen will have first dibs on new medicines emerging from a research team led by Jamie Rossjohn of Monash’s Biomedicine Discovery Institute that is studying early detection and treatment of the crippling disease suffered by 400,000 Australians and 25 million worldwide.
